SV

Sri Varshini Garimella

Active Director Director DIN 10903851
DIN 10903851 First appointment Jan 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value •••• Premium profile

About Sri Varshini Garimella

Data last updated:

Sri Varshini Garimella is a Director at Nyasa Pharma Private Limited (since 2025). The company operates in Healthcare. Nyasa Pharma Private Limited reported revenue of ₹1.97 Cr (FY 2025).

DIN 10903851
Primary Designation Director
Industry Healthcare
First Appointment 17 Jan 2025
Oldest Company Age 12 yrs
Largest company Nyasa Pharma Private Limited · ₹1.97 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nyasa Pharma Private Limited U24233TG2014PTC092228
Director17 Jan 20252014₹1.97 Cr (FY 2025)Active

Board colleagues of Sri Varshini Garimella

Directorship timeline

Open interactive timeline →
Nyasa Pharma Private Limited
Premium access

Shareholding and investment profile for Sri Varshini Garimella

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sri Varshini Garimella

Sri Varshini Garimella currently holds 1 directorship: Nyasa Pharma Private Limited (Director, since 17 Jan 2025, revenue ₹1.97 Cr (FY 2025)).

Sri Varshini Garimella was first appointed on 17 Jan 2025 as Director at Nyasa Pharma Private Limited.

The current boards of Sri Varshini Garimella's companies include Kadiyala Venkata Naga Parvateesa Sai Chandra (Nyasa Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available